Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups

被引:51
作者
Haffty, B. G. [3 ]
Choi, D. H. [1 ]
Goyal, S.
Silber, A. [5 ]
Ranieri, K. [8 ]
Matloff, E. [4 ]
Lee, M. H. [2 ]
Nissenblatt, M. [6 ]
Toppmeyer, D. [6 ]
Moran, M. S. [7 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea
[2] Soonchunhyang Univ, Coll Med, Dept Surg, Seoul, South Korea
[3] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, Canc Inst New Jersey, New Brunswick, NJ 08901 USA
[4] Yale Univ, Sch Med, Dept Med Genet, New Haven, CT 06520 USA
[5] Yale Univ, Sch Med, Dept Med, Sect Med Oncol, New Haven, CT 06520 USA
[6] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Sect Med Oncol, New Brunswick, NJ 08901 USA
[7] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA
[8] Canc Inst New Jersey, Med Genet Sect, New Brunswick, NJ USA
关键词
BRCA1; BRCA2; breast cancer; genetics; race; REDUCING SALPINGO-OOPHORECTOMY; OVARIAN-CANCER; GERMLINE MUTATIONS; AFRICAN-AMERICAN; PROPHYLACTIC MASTECTOMY; FAMILY-HISTORY; CARRIERS; SUSCEPTIBILITY; EPIDEMIOLOGY;
D O I
10.1093/annonc/mdp051
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Methods: Patients presenting to our breast cancer follow-up clinics selected solely on having a known breast cancer diagnosis at a young age (YBC defined as age < 45 years at diagnosis) were invited to participate in this study. A total of 333 eligible women, 166 CA, 66 AA and 101 KO underwent complete sequencing of BRCA1/2 genes. Family history (FH) was classified as negative, moderate or strong. BRCA1/2 status was classified as wild type (WT), variant of uncertain significance (VUS) or deleterious (DEL). Results: DEL across these three racially diverse populations of YBC were nearly identical: CA 17%, AA 14% and KO 14%. The type of DEL differed with AA having more frequent mutations in BRCA2, compared with CA and KO. VUS were predominantly in BRCA2 and AA had markedly higher frequency of VUS (38%) compared with CA (10%) and KO (12%). At 10-year follow-up from the time of initial diagnosis of breast cancer, the risk of secondary malignancies was similar among WT (14%) and VUS (16%), but markedly higher among DEL (39%). Conclusions: In these YBC, the frequency of DEL in BRCA1/2 is remarkably similar among the racially diverse groups at 14%-17%. VUS is more common in AA, but aligns closely with WT in risk of second cancers, age of onset and FH.
引用
收藏
页码:1653 / 1659
页数:7
相关论文
共 48 条
[1]   BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations [J].
Ahn, Sei Hyun ;
Son, Byung Ho ;
Yoon, Kyung-Sik ;
Noh, Dong-Young ;
Han, Wonshik ;
Kim, Sung-Won ;
Lee, Eun Sook ;
Park, Hai-Lin ;
Hong, Young Joon ;
Choi, Jae Jin ;
Moon, Seo Yun ;
Kim, Mi Jeong ;
Kim, Kye Hyun ;
Kwak, Beom Seok ;
Cho, Dae-Yeon .
CANCER LETTERS, 2007, 245 (1-2) :90-95
[2]  
Ahn SH, 2004, ARCH SURG-CHICAGO, V139, P27
[3]  
[Anonymous], CLIN BREAST CANC
[4]   Fanconi anemia [J].
Bagby, Grover C. ;
Alter, Blanche P. .
SEMINARS IN HEMATOLOGY, 2006, 43 (03) :147-156
[5]  
Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310
[6]   American Society of Clinical Oncology policy statement update: Genetic testing for cancer susceptibility [J].
Bruinooge, SS .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) :2397-2406
[7]  
Chang J, 2001, CLIN CANCER RES, V7, P1739
[8]   Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients [J].
Choi, DH ;
Lee, NH ;
Bale, AE ;
Carter, D ;
Haffty, BG .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (09) :1638-1645
[9]  
CHOI DH, 2008, BREAST CANC RES TREA
[10]   Assessment of Functional Effects of Unclassified Genetic Variants [J].
Couch, Fergus J. ;
Rasmussen, Lene Juel ;
Hofstra, Robert ;
Monteiro, Alvaro N. A. ;
Greenblatt, Marc S. ;
de Wind, Niels .
HUMAN MUTATION, 2008, 29 (11) :1314-1326